(2026). "Fluid-absorptive gastroretentive dosage form for prolonged drug delivery" in Patent Application Approval Process (USPTO 20260183230). Pharma Business Week, 2093.
Chicago Style (17th ed.) Citation""Fluid-absorptive Gastroretentive Dosage Form for Prolonged Drug Delivery" in Patent Application Approval Process (USPTO 20260183230)." Pharma Business Week 2026: 2093.
MLA (9th ed.) Citation""Fluid-absorptive Gastroretentive Dosage Form for Prolonged Drug Delivery" in Patent Application Approval Process (USPTO 20260183230)." Pharma Business Week, 2026, p. 2093.
Warning: These citations may not always be 100% accurate.
